S

Synthaverse
SVE

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
PLN258.31M
EV
PLN345.50M
Shares Outstanding
70.77M
Beta
0.13
Industry
Biotechnology

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2025E
-
P/Revenue 2025E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
-
Net Profit Margin 2025E
-
ROE 2025E
-
ROCE 2024
6.45%

Dividends

DPS 2025E
-
Payout Ratio 2025E
-
Div. Yield 2025E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Synthaverse S.A.

gainify

S

Synthaverse S.A.

SVE

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally. It operates through BCG and Traditional segments. The company offers OnkoBCG...

Sector

Healthcare

Industry

Biotechnology

CEO

Starkowicz, Mieczyslaw

Employees

239

IPO Date

2011-07-29

Headquarters

ul. Uniwersytecka 10, Lublin 20-029, Poland

📊 Stock Price & Performance

The last closing price of Synthaverse (SVE) is PLN3.68, reflecting a +1.66% change from the prior session. Last updated: December 30, 2025 at 10:53 AM Eastern Time

Review the recent SVE stock performance trends:Past 1 Month: Synthaverse (SVE) shares have -9.65%.Past 3 Months: The stock has -16.67%.Past 6 Months: SVE shares have -30.48%. Last updated: January 1, 2026 at 12:20 AM Eastern Time

Over the last year, Synthaverse (SVE) has established a 52-week price range between a high of PLN5.91 and a low of PLN3.51. This metric is essential for assessing the stock's annual volatility. Last updated: January 1, 2026 at 12:20 AM Eastern Time

Synthaverse (SVE) is considered a low volatility stock. It has a beta of 0.13, which means it typically moves 0.13 times as much as the broader market. Over the past 52 weeks, SVE has traded within a PLN3.51 – PLN5.91 range. Last updated: January 1, 2026 at 12:20 AM Eastern Time

A PLN1,000 investment in Synthaverse 5 years ago, when the stock was trading around PLN9.03, would be worth approximately PLN407.37 today, based solely on share price performance (excluding dividends). This represents a total return of -59.26% over the period, equivalent to a compound annual growth rate (CAGR) of -16.44%. Past performance reflects historical price movements only and does not imply future results. Last updated: January 1, 2026 at 12:20 AM Eastern Time

💰 Financial Metrics & Reports

The current Synthaverse (SVE) market capitalization is approximately PLN258.31M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Synthaverse's market cap fluctuates with changes in its share price and share count. Last updated: January 1, 2026 at 12:20 AM Eastern Time

In the most recently reported quarter, Synthaverse (SVE) generated PLN4.79M in revenue, representing a -64.28% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 4:28 AM Eastern Time

In the most recently reported fiscal year, Synthaverse (SVE) generated net income of PLN7.55M, compared with PLN4.76M in the prior fiscal year, representing a +58.68% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 4:28 AM Eastern Time

According to its latest quarterly filing, Synthaverse (SVE) reported EBITDA of PLN-4.20M, representing a -272.02% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 4:28 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.67x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 4:28 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Synthaverse (SVE) revenue was PLN4.79M. Earnings per share (EPS) for the quarter were PLN-0.11. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 4:28 AM Eastern Time

Synthaverse (SVE) does not currently pay a dividend. Over the last twelve months (LTM), the company paid PLN0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 4:28 AM Eastern Time

📈 Analyst Information

Based on the latest available analyst coverage, Synthaverse (SVE) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 4:28 AM Eastern Time

Like other publicly traded stocks, Synthaverse (SVE) shares are bought and sold on stock exchanges such as WSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Synthaverse (SVE) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add SVE to your watchlist.

Synthaverse trades under the ticker symbol SVE on the WSE stock exchange. The ticker SVE is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Synthaverse (SVE) employs approximately 239 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: January 1, 2026 at 12:20 AM Eastern Time

Synthaverse (SVE) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Synthaverse (SVE) stock peers based on overlapping products, services, and competitive dynamics:BioInvent International (BINV)Inventiva (IVA)Bioventix (BVXP)Xbrane Biopharma (XBRANE)Jiangsu Gdk Biological Technology (688670)Prothena Corporation (PRTA) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Synthaverse.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.